The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Epiretinal Membrane

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Epiretinal Membrane


High impact information on Epiretinal Membrane


Chemical compound and disease context of Epiretinal Membrane


Biological context of Epiretinal Membrane


Anatomical context of Epiretinal Membrane


Gene context of Epiretinal Membrane


Analytical, diagnostic and therapeutic context of Epiretinal Membrane


  1. Hepatocyte growth factor receptor in human RPE cells: implications in proliferative vitreoretinopathy. Lashkari, K., Rahimi, N., Kazlauskas, A. Invest. Ophthalmol. Vis. Sci. (1999) [Pubmed]
  2. Polymerase chain reaction for detection of Mycobacterium tuberculosis in epiretinal membrane in Eales' disease. Madhavan, H.N., Therese, K.L., Gunisha, P., Jayanthi, U., Biswas, J. Invest. Ophthalmol. Vis. Sci. (2000) [Pubmed]
  3. Proliferative vitreoretinopathy. Lymphocytes in epiretinal membranes. Charteris, D.G., Hiscott, P., Grierson, I., Lightman, S.L. Ophthalmology (1992) [Pubmed]
  4. Hypothesis concerning carbonic anhydrase treatment of cystoid macular edema: example with epiretinal membrane. Marmor, M.F. Arch. Ophthalmol. (1990) [Pubmed]
  5. Vitreous hemorrhage in infants. Ferrone, P.J., de Juan, E. Arch. Ophthalmol. (1994) [Pubmed]
  6. Platelet-derived growth factor is an autocrine growth stimulator in retinal pigmented epithelial cells. Campochiaro, P.A., Hackett, S.F., Vinores, S.A., Freund, J., Csaky, C., LaRochelle, W., Henderer, J., Johnson, M., Rodriguez, I.R., Friedman, Z. J. Cell. Sci. (1994) [Pubmed]
  7. Apoptosis in proliferative vitreoretinopathy. El Ghrably, I., Powe, D.G., Orr, G., Fischer, D., McIntosh, R., Dua, H.S., Tighe, P.J. Invest. Ophthalmol. Vis. Sci. (2004) [Pubmed]
  8. Outcome of vitreous surgery and the balance between vascular endothelial growth factor and endostatin. Funatsu, H., Yamashita, H., Noma, H., Mochizuki, H., Mimura, T., Ikeda, T., Hori, S. Invest. Ophthalmol. Vis. Sci. (2003) [Pubmed]
  9. Direct comparison of the migration of three cell types involved in epiretinal membrane formation. Hogg, P.A., Grierson, I., Hiscott, P. Invest. Ophthalmol. Vis. Sci. (2002) [Pubmed]
  10. Active scatter factor (HGF/SF) in proliferative vitreoretinal disease. Briggs, M.C., Grierson, I., Hiscott, P., Hunt, J.A. Invest. Ophthalmol. Vis. Sci. (2000) [Pubmed]
  11. Intravitreal daunomycin induces multidrug resistance in proliferative vitreoretinopathy. Esser, P., Tervooren, D., Heimann, K., Kociok, N., Bartz-Schmidt, K.U., Walter, P., Weller, M. Invest. Ophthalmol. Vis. Sci. (1998) [Pubmed]
  12. Trypan blue staining in vitreoretinal surgery. Teba, F.A., Mohr, A., Eckardt, C., Wong, D., Kusaka, S., Joondeph, B.C., Feron, E.J., Stalmans, P., Van Overdam, K., Melles, G.R. Ophthalmology (2003) [Pubmed]
  13. Fundus photographic and fluorescein angiographic characteristics of pseudoholes of the macula in eyes with epiretinal membranes. Klein, B.R., Hiner, C.J., Glaser, B.M., Murphy, R.P., Sjaarda, R.N., Thompson, J.T. Ophthalmology (1995) [Pubmed]
  14. Chondroitin sulfate-induced generation of epiretinal membranes. Russell, S.R., Hageman, G.S. Arch. Ophthalmol. (1992) [Pubmed]
  15. Local production of fibronectin by ectopic human retinal cells. Hiscott, P., Waller, H.A., Grierson, I., Butler, M.G., Scott, D. Cell Tissue Res. (1992) [Pubmed]
  16. The effect of pars plana vitrectomy and transforming growth factor-beta 2 without epiretinal membrane peeling on full-thickness macular holes. Lansing, M.B., Glaser, B.M., Liss, H., Hanham, A., Thompson, J.T., Sjaarda, R.N., Gordon, A.J. Ophthalmology (1993) [Pubmed]
  17. Trypan blue staining of internal limiting membrane and epiretinal membrane during vitrectomy: visual results and histopathological findings. Li, K., Wong, D., Hiscott, P., Stanga, P., Groenewald, C., McGalliard, J. The British journal of ophthalmology. (2003) [Pubmed]
  18. Expression of glutamine synthetase and cell proliferation in human idiopathic epiretinal membrane. Kase, S., Saito, W., Yokoi, M., Yoshida, K., Furudate, N., Muramatsu, M., Saito, A., Kase, M., Ohno, S. The British journal of ophthalmology. (2006) [Pubmed]
  19. Diabetic patients and retinal proliferation: an evaluation of the role of vascular endothelial growth factor (VEGF). Nicoletti, V.G., Nicoletti, R., Ferrara, N., Meli, G., Reibaldi, M., Reibaldi, A. Exp. Clin. Endocrinol. Diabetes (2003) [Pubmed]
  20. Simultaneous expression of keratin and glial fibrillary acidic protein by the same cells in epiretinal membranes. Vinores, S.A., Van Niel, E., Kim, H.J., Campochiaro, P.A. Invest. Ophthalmol. Vis. Sci. (1992) [Pubmed]
  21. Glial cell expression of hepatocyte growth factor in vitreoretinal proliferative disease. Hollborn, M., Krausse, C., Iandiev, I., Yafai, Y., Tenckhoff, S., Bigl, M., Schnurrbusch, U.E., Limb, G.A., Reichenbach, A., Kohen, L., Wolf, S., Wiedemann, P., Bringmann, A. Lab. Invest. (2004) [Pubmed]
  22. Vascular endothelial growth factor and fibroblast growth factor 5 are colocalized in vascular and avascular epiretinal membranes. Schneeberger, S.A., Hjelmeland, L.M., Tucker, R.P., Morse, L.S. Am. J. Ophthalmol. (1997) [Pubmed]
  23. Trypan blue has a high affinity to cellular structures such as epiretinal membrane. Meyer, C.H., Rodrigues, E.B., Kroll, P. Am. J. Ophthalmol. (2004) [Pubmed]
  24. Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF. Hollborn, M., Tenckhoff, S., Jahn, K., Iandiev, I., Biedermann, B., Schnurrbusch, U.E., Limb, G.A., Reichenbach, A., Wolf, S., Wiedemann, P., Kohen, L., Bringmann, A. Mol. Vis. (2005) [Pubmed]
  25. Immunohistochemical localization of epidermal growth factor receptor in a human epiretinal membrane. Heidenkummer, H.P., Kampik, A. Graefes Arch. Clin. Exp. Ophthalmol. (1991) [Pubmed]
  26. Basic fibroblast growth factor mRNA, bFGF peptide and FGF receptor in epiretinal membranes of intraocular proliferative disorders (PVR and PDR). Hueber, A., Wiedemann, P., Esser, P., Heimann, K. International ophthalmology. (1996) [Pubmed]
  27. Visual outcomes after pars plana vitrectomy for epiretinal membranes associated with pars planitis. Dev, S., Mieler, W.F., Pulido, J.S., Mittra, R.A. Ophthalmology (1999) [Pubmed]
  28. Viscodelamination at the vitreoretinal juncture in severe diabetic eye disease. McLeod, D., James, C.R. The British journal of ophthalmology. (1988) [Pubmed]
  29. Fluorouracil therapy for proliferative vitreoretinopathy after vitrectomy. Stern, W.H., Lewis, G.P., Erickson, P.A., Guerin, C.J., Anderson, D.H., Fisher, S.K., O'Donnell, J.J. Am. J. Ophthalmol. (1983) [Pubmed]
  30. The effect of prinomastat (AG3340), a potent inhibitor of matrix metalloproteinase, on a new animal model of epiretinal membrane. El-Bradey, M.H., Cheng, L., Bartsch, D.U., Niessman, M., El-Musharaf, A., Freeman, W.R. Retina (Philadelphia, Pa.) (2004) [Pubmed]
WikiGenes - Universities